Monday, January 20, 2025SCCS
Children's exposure to Butylparaben and Salicylic Acid: preliminary Opinions of the SCCS
As part of its assessment of the safety of substances that may have endocrine disrupting properties, the SCCS published its Final Opinions on Butylparaben (in October 2023) and Salicylic Acid (in June 2023), each time expressing reservations about the use in children’s products. As the industry has provided data to defend this use, the Scientific Committee reconsidered the issue, and has just published its preliminary Opinions.